Parametric Portfolio Associates’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$37K Sell
755
-1,624
-68% -$97.6K ﹤0.01% 3644
2021
Q4
$167K Sell
2,379
-1,483
-38% -$160K ﹤0.01% 3458
2021
Q3
$564K Buy
3,862
+3,574
+1,241% +$1.08M ﹤0.01% 3046
2021
Q2
$177K Buy
+288
New +$188K ﹤0.01% 3427

Other funds holding MDVL

Parametric Portfolio Associates's MDVL Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its MedAvail Holdings, Inc. Common Stock (MDVL) stake by 68% in Q1 2022, selling an estimated $97.6K and leaving 755 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #3644.

Parametric Portfolio Associates first reported a position in MDVL in Q2 2021 and has held it in 4 quarters since. The position peaked at $564K in Q3 2021. 49 funds tracked by Wall St. Rank hold MDVL as of Q1 2022.

  • Parametric Portfolio Associates held 755 shares of MedAvail Holdings, Inc. Common Stock worth $37K as of Q1 2022.
  • Parametric Portfolio Associates sold 1,624 MedAvail Holdings, Inc. Common Stock shares in Q1 2022, an estimated $97.6K.
  • MedAvail Holdings, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3644 holding.
  • Parametric Portfolio Associates first reported a position in MedAvail Holdings, Inc. Common Stock in Q2 2021 and has held it in 4 quarters since.
  • Parametric Portfolio Associates's MedAvail Holdings, Inc. Common Stock position peaked at $564K in Q3 2021.
  • 49 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.